Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02328534
Other study ID # AlBarakaSD1
Secondary ID
Status Completed
Phase N/A
First received December 28, 2014
Last updated December 30, 2014
Start date March 2007
Est. completion date January 2014

Study information

Verified date December 2014
Source Al Baraka Fertility Hospital
Contact n/a
Is FDA regulated No
Health authority Bahrain: Ethics CommitteeEgypt: Ministry of Health and Population
Study type Observational

Clinical Trial Summary

The investigators evaluate the feedback of using swim down semen processing method during preparation for ICSI and compare the results of pregnancy and embryos quality with the cases used density gradient method for their semen processing.


Description:

There is different semen processing method, in this study we compared the ICSI output when the investigators used one method with higher separation method and minimum sperm stress or physical interface as swimming down using 100 % silica solution, with other more stressful procedure with high selection power as density gradient.

The routine used method as density gradient (DG) includes about 30 min centrifugation at 1200 RPM, and more working steps with more handling procedures. According to many references the investigators can approve that it is method to be indicated with all cases particularly with those severely decreases semen number or motility.

Using 100 % silica solution for semen processing used for ICSi, shews lesser centrifugation time and minimum processing procedures. As swimming down time is about 30 min followed by 5 min washing and finalized with other 3 minutes last wash. For that total interfering physical action is about 8 minutes compared with 30 min with DG method.

In swimming down we are using the natural sperm behavior and own swimming power for separate itself from other seminal components. As well as only the one normally structure and motility direction the only can penetrate the interface surface of silica solution and swim inside higher density matrix using its speed and power.


Recruitment information / eligibility

Status Completed
Enrollment 890
Est. completion date January 2014
Est. primary completion date September 2013
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 38 Years
Eligibility Inclusion Criteria: all semen samples fresh or frozen that has,

- Cases have semen examination criteria fall within WHO 2010 standards of count

- Cases have semen examination criteria fall within WHO 2010 standards of motility

- Cases have semen examination criteria with all types of abnormal forms

- Cases produced more than 4 mature oocytes (M2) and more

Exclusion Criteria:

- Cases have semen examination criteria with motility less than 5%

- Cases have semen examination criteria with count less than 1.0 million

- Cases with TESE, TESA and EPSA, both fresh and frozen

- Cases produced less than 4 mature oocytes (M2)

Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


Intervention

Behavioral:
Blastocyst Formation Rate
Embryos developed at Day3 cultures, are continued for Day5 culture tho reach blastocyst stage. The percentage of blastocyst produced from cleaved embryos to be evaluated ar rate. The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time.
Procedure:
Blastocyst Rate
Day 5 embryo transfer achieved pregnancy are compared with total embryo transfer cases at Day5. The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time. Pregnancy confirmed with day 12 after Et and repeated with 48 hours after 1st exam.
Pregnancy Rate
All pregnancy achieved from all ET. Pregnancy confirmed with day 12 after Et and repeated with 48 hours after 1st exam. The evaluation with doe one time using Density Gradient semen one time and Swimming down semen another time.

Locations

Country Name City State
Bahrain Al Baraka Fertility Hospital Manama Adliyah
Egypt Ibn Sina IVF Center- Ibn Sina Hospital Sohag

Sponsors (1)

Lead Sponsor Collaborator
Ahmad Mustafa Mohamed Metwalley

Countries where clinical trial is conducted

Bahrain,  Egypt, 

References & Publications (1)

Malvezzi H, Sharma R, Agarwal A, Abuzenadah AM, Abu-Elmagd M. Sperm quality after density gradient centrifugation with three commercially available media: a controlled trial. Reprod Biol Endocrinol. 2014 Dec 2;12:121. doi: 10.1186/1477-7827-12-121. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Total Pregnancy Rate Percentage of Pregnancies developed after embryo transfer, for maternal age less than 38 years old. 3 Years Yes
Secondary Blastulation Rate (BR) Percentage of blastocyst embryos produced from cleaved embryos, for maternal age less than 38 YO. 3 years Yes
Secondary Blastocyst formation Rate (BFR) Developed embryos developed to Blastocyst stage from cleaved embryos. 3 Years Yes
See also
  Status Clinical Trial Phase
Completed NCT03607409 - Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Recruiting NCT02312076 - GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Phase 4
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Completed NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Terminated NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Completed NCT04496284 - Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen N/A
Completed NCT03623659 - pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts N/A
Completed NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors Phase 3
Active, not recruiting NCT04142112 - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation N/A
Completed NCT03152643 - Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer N/A
Recruiting NCT03683771 - Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
Recruiting NCT03161119 - Comparing Two Different Embryo Transfer Catheters N/A
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Completed NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) N/A
Completed NCT03678558 - Oocyte Vitrification Aided With Cytochalasin B N/A
Completed NCT03678571 - Oocyte Vitrification Aided With Latrunculin A N/A
Completed NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) N/A
Completed NCT03677492 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD) N/A
Completed NCT03678610 - Handling Medium for ICSI With Ionomycin and Latrunculin A N/A
Completed NCT03678597 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB) N/A